Chair of Pharmacology, Section of Medicine, University of Fribourg, 1700 Fribourg, Switzerland.
Biomolecules. 2020 Mar 13;10(3):447. doi: 10.3390/biom10030447.
3-mercaptopyruvate sulfurtransferase (3-MST) has emerged as one of the significant sources of biologically active sulfur species in various mammalian cells. The current study was designed to investigate the functional role of 3-MST's catalytic activity in the murine colon cancer cell line CT26. The novel pharmacological 3-MST inhibitor HMPSNE was used to assess cancer cell proliferation, migration and bioenergetics in vitro. Methods included measurements of cell viability (MTT and LDH assays), cell proliferation and in vitro wound healing (IncuCyte) and cellular bioenergetics (Seahorse extracellular flux analysis). 3-MST expression was detected by Western blotting; HS production was measured by the fluorescent dye AzMC. The results show that CT26 cells express 3-MST protein and mRNA, as well as several enzymes involved in HS degradation (TST, ETHE1). Pharmacological inhibition of 3-MST concentration-dependently suppressed HS production and, at 100 and 300 µM, attenuated CT26 proliferation and migration. HMPSNE exerted a bell-shaped effect on several cellular bioenergetic parameters related to oxidative phosphorylation, while other bioenergetic parameters were either unaffected or inhibited at the highest concentration of the inhibitor tested (300 µM). In contrast to 3-MST, the expression of CBS (another HS producing enzyme which has been previously implicated in the regulation of various biological parameters in other tumor cells) was not detectable in CT26 cells and pharmacological inhibition of CBS exerted no significant effects on CT26 proliferation or bioenergetics. In summary, 3-MST catalytic activity significantly contributes to the regulation of cellular proliferation, migration and bioenergetics in CT26 murine colon cancer cells. The current studies identify 3-MST as the principal source of biologically active HS in this cell line.
3-巯基丙酮酸硫转移酶 (3-MST) 已成为各种哺乳动物细胞中生物活性硫物种的重要来源之一。本研究旨在探讨 3-MST 的催化活性在小鼠结肠癌细胞系 CT26 中的功能作用。使用新型药理学 3-MST 抑制剂 HMPSNE 来评估癌症细胞在体外的增殖、迁移和生物能量学。方法包括细胞活力(MTT 和 LDH 测定)、细胞增殖和体外伤口愈合(IncuCyte)和细胞生物能量学( Seahorse 细胞外通量分析)的测量。通过 Western blot 检测 3-MST 表达;通过荧光染料 AzMC 测量 HS 产生。结果表明,CT26 细胞表达 3-MST 蛋白和 mRNA,以及几种参与 HS 降解的酶(TST、ETHE1)。3-MST 的药理学抑制浓度依赖性地抑制 HS 产生,在 100 和 300 µM 时,减弱 CT26 的增殖和迁移。HMPSNE 对与氧化磷酸化相关的几种细胞生物能量学参数产生钟形效应,而其他生物能量学参数在测试的抑制剂最高浓度下不受影响或被抑制(300 µM)。与 3-MST 相反,CBS(另一种 HS 产生酶,先前已被发现在其他肿瘤细胞中调节各种生物学参数)在 CT26 细胞中不可检测,并且 CBS 的药理学抑制对 CT26 的增殖或生物能量学没有显著影响。总之,3-MST 的催化活性显著促进 CT26 小鼠结肠癌细胞的细胞增殖、迁移和生物能量学的调节。目前的研究将 3-MST 鉴定为该细胞系中生物活性 HS 的主要来源。